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NKG2D is an activating immunoreceptor on 
NK cells, activated CD8 T cells, a subset of CD4 
T cells, NKT cells, and T cells. The ligands 
for NKG2D are self-proteins that are poorly 
expressed by normal cells but up-regulated 
in distressed cells. Upon engagement, NKG2D 
induces activation of lymphocytes, which leads 
to the cytolysis of target cells and cytokine pro-
duction. Accordingly, NKG2D has been shown 
to play a major role in the activity of NK cells 
and T cells against target cells in vitro and to be 
protective in the context of certain cancers and 
infections in vivo (Raulet, 2003; Guerra et al., 
2008; Raulet and Guerra, 2009; Champsaur 
and Lanier, 2010). There is a surprising diversity 
of NKG2D ligands, up to nine in mice and 
eight in humans, depending on the strain or in-
dividual. In mice, the ligands include five mem-
bers of the retinoic acid early inducible gene 1 
(RAE-1; –) subfamily, murine UL16–binding 
protein-like transcript 1 (MULT1), and three 
members of the histocompatibility (H60; a–c) 
family (Raulet, 2003; Champsaur and Lanier, 
2010). In humans, the ligands include RAET1s 
(also known as ULBPs), MICA, and MICB 
(Eagle and Trowsdale, 2007; Champsaur and 
Lanier, 2010).
The ligands are frequently found on the 
surface of immortalized mouse tumor cell lines, 
established cell lines and primary tumors (Guerra 
et al., 2008), and cells infected with certain 
pathogens (Champsaur and Lanier, 2010). Evi-
dence suggests that ligands are induced through 
cellular pathways activated by extrinsic stresses, 
including the DNA damage response, heat shock 
stress, and, in some cases, tumor suppressors, but 
most of these act posttranscriptionally and lit-
tle is known concerning the transcriptional 
induction of ligand genes in unhealthy cells 
(see Discussion). Therefore, a major outstanding 
question in the field is how NKG2D ligands 
are regulated transcriptionally and how such 
regulation is coupled to cellular processes asso-
ciated with disease.
One of the most common themes in the 
process of tumorigenesis is deregulation of the 
cell cycle, especially in factors that control 
the G1/S transition, which heavily relies on the 
activity of E2F transcription factors. The E2F 
CORRESPONDENCE  
David H. Raulet: 
raulet@berkeley.edu
Abbreviations used: ATM, 
ataxia-telangiectasia mutated; 
CDK, cyclin-dependent kinase; 
CHK1, checkpoint kinase 1; 
EMSA, electrophoretic mobility 
shift assay; H60a, histocompat-
ibility 60; MULT1, murine 
UL16-binding protein-like 
transcript 1; RAE-1, retinoic 
acid early inducible gene 1.
RAE-1 ligands for the NKG2D receptor  
are regulated by E2F transcription factors, 
which control cell cycle entry
Heiyoun Jung, Benjamin Hsiung, Kathleen Pestal, Emily Procyk,  
and David H. Raulet
Department of Molecular and Cell Biology, and Cancer Research Laboratory, 489 Life Sciences Addition,  
University of California, Berkeley, Berkeley, CA 94720
The NKG2D stimulatory receptor expressed by natural killer cells and T cell subsets recog-
nizes cell surface ligands that are induced on transformed and infected cells and facilitate 
immune rejection of tumor cells. We demonstrate that expression of retinoic acid early 
inducible gene 1 (RAE-1) family NKG2D ligands in cancer cell lines and proliferating normal 
cells is coupled directly to cell cycle regulation. Raet1 genes are directly transcriptionally 
activated by E2F family transcription factors, which play a central role in regulating cell 
cycle entry. Induction of RAE-1 occurred in primary cell cultures, embryonic brain cells in 
vivo, and cells in healing skin wounds and, accordingly, wound healing was delayed in mice 
lacking NKG2D. Transcriptional activation by E2Fs is likely coordinated with posttranscrip-
tional regulation by other stress responses. These findings suggest that cellular prolifera-
tion, as occurs in cancer cells but also other pathological conditions, is a key signal tied to 
immune reactions mediated by NKG2D-bearing lymphocytes.
© 2012 Jung et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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RESULTS
Robust RAE-1 expression is induced in primary  
cultures and depends on cell proliferation
To study the regulation of NKG2D ligands in cells that retain 
normal checkpoint pathways, primary cultures of fibroblasts 
were prepared from the tails of adult B6 mice. Unexpectedly, 
without any additional treatments, RAE-1 transcripts and 
cell surface expression were detected in fibroblasts within 2 d 
of the initiation of culture and reached a plateau after 6 d of 
culture (Fig. 1, A and B). Expression was maintained indefi-
nitely thereafter in the cultures for up to a year when they 
were maintained in growth-inducing conditions. Similar 
results were obtained in primary fibroblast cultures prepared 
from peritoneal wall and ear tissues (unpublished data). Hence, 
primary culture conditions were sufficient to induce RAE-1 
in the absence of other known stressors.
Induction in proliferating cells was characteristic of some 
NKG2D ligands, but not others. Both of the Raet1 genes 
identified in B6 mice were induced in proliferating primary 
family consists of eight transcription factors that fall into 
two groups depending on whether they activate transcrip-
tion (E2F1, E2F2, and E2F3a) or repress it (E2F4-8 and 
E2F3b; Chen et al., 2009). Activator E2Fs are expressed in 
response to growth factor stimulation and oncogenic stress 
and induce transcription of target genes involved in cell 
cycle progression and DNA replication. As a result of its 
critical role in proliferation, the regulatory pathway for E2Fs 
is one of the most dysregulated pathways in cancer (Chen 
et al., 2009).
In this study, we have identified proliferative signals 
generally, and E2F transcription factors specifically, as a ma-
jor mechanism of transcriptional regulation of the NKG2D 
ligand Raet1e that leads to the cell surface expression of 
RAE-1. The coupling of RAE-1 expression to prolifera-
tive signals provides a mechanism for surveillance of aber-
rantly proliferating cells but raises interesting questions 
concerning how normal and pathological proliferation is 
distinguished by the immune system.
Figure 1. RAE-1e is induced on primary cultured fibroblasts dependent on proliferation. (A) qRT-PCR for Raet1e in RNA from adult 
C57BL/6 tail tissue (day 0), or 2- or 10-d cultured fibroblasts from the tails, relative to 18s rRNA qRT-PCR results. Raet1e transcript levels were 
normalized to the day 2 amounts, as they were undetectable in day 0 cells. Means ± SD are shown. **, P < 0.005, unpaired Student’s t test. (B) Tail 
fibroblasts harvested after 1–6 d of in vitro culture were stained with RAE-1 antibody. Shaded histogram represents isotype control staining.  
(C) qRT-PCR for Raet1e, Raet1d, Mult1, and H60b in RNA from adult C57BL/6 tail tissue (d0), or 5-d cultured fibroblasts (d5) from the tails, rela-
tive to 18s rRNA qRT-PCR results. Means ± SD are shown. (D) Tail fibroblasts were cultured with DMSO or with 10 mM LY294002 or 25 mM 
Roscovitine for the indicated number of days and stained for RAE-1. (E) After 8 d of primary culture in 10% FCS, fibroblasts were treated with 
LY294002, Roscovitine, or vehicle (DMSO) for 3 d and stained for RAE-1 (top). RAE-1 staining was tested after washing the treated cells from 
the top panel and reculturing for an additional 3 d (bottom). (F) TRAMP-C2 and MC38 tumor cell lines were treated with Roscovitine or vehicle 
(DMSO) for 1 or 3 d and stained for RAE-1. Shaded histograms represent isotype control staining of DMSO-treated samples. (G) HCT116 cells 
were serum starved or treated with Roscovitine or vehicle (DMSO) for 3 d and stained for MICA/B or UBLP2. Dead (7-AAD+) cells were excluded in 
all of the experiments above, except one in A. Data in A, B, and D were repeated >10× with similar results, and data in C, E, F, and G are represen-
tative of two to three independent experiments.
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Therefore, down-regulation of RAE-1 in these studies was 
not associated with apoptosis or senescence but rather with 
the nonproliferating state.
Analysis of cells that incorporated BrdU or not in the 
first 24 h after serum restoration showed that BrdU+ cells 
expressed RAE-1, whereas BrdU-negative cells did not 
(Fig. 2 G), further strengthening the relationship between pro-
liferation and RAE-1 expression. In an established proliferat-
ing cell population, cell surface RAE-1 expression did not vary 
significantly between different cell cycle stages (Fig. 2 H), but 
it is possible that this reflects the stability of the RAE-1 pro-
tein or mRNA. It proved extremely difficult to test whether 
transcription of Raet1 genes varies in different cell cycle stages.
RAE-1 was induced to a similar extent on primary fi-
broblasts cultured for 3 d with serum or with serum-free 
medium supplemented with a defined growth factor that is 
known to be present in serum (EGF; Loo et al., 1987), argu-
ing against the possibility that serum factors other than growth 
factors are important for RAE-1 induction (Fig. 2 I). Cells 
cultured in serum-free medium lacking EGF did not prolif-
erate and failed to induce RAE-1 on the surface. Together, 
these data provided evidence that RAE-1 expression in 
primary cultures is linked to cellular proliferation and that 
continuous proliferation is required to maintain RAE-1 ex-
pression on the cell surface.
Cytotoxicity assays were performed to determine whether 
RAE-1 induction resulting from cell proliferation rendered 
the cells sensitive to NK killing. Proliferating fibroblasts were 
efficiently killed by IL-2–activated NK cells, but killing was 
significantly reduced when the NK cells were derived from 
NKG2D-deficient (Klrk1/) mice (KO) or blocked with 
NKG2D antibody, demonstrating that NKG2D ligand ex-
pression by the fibroblasts induced increased NK killing 
(Fig. 2 J). If the fibroblasts were starved of serum for 3 d, they 
displayed lower RAE-1 at the cell surface (not depicted) and 
required more than three times as many NK cells to be lysed 
to the same extent as the proliferating fibroblasts (Fig. 2 J). 
The residual killing of starved fibroblasts was presumably a 
result of the expression of ligands for other NK cell receptors 
because it did not decrease significantly even when NKG2D-
deficient (Klrk1/) NK cells were used as effector cells 
(unpublished data). These data showed that reduced RAE-1 
expression in starved cells was associated with reduced NK 
killing of the cells.
Role of stress pathways activated in primary cell cultures
Primary culture conditions can induce a DNA damage re-
sponse in fibroblasts (Parrinello et al., 2003), which we con-
firmed by demonstrating nuclear foci containing H2AX 
(Mah et al., 2010) on fibroblasts after 5 d of primary culture 
(unpublished data). Although previous studies demonstrated 
that an activated DNA damage response can induce RAE-1 
expression in cultured cell lines and some T cell cultures 
(Gasser et al., 2005; Cerboni et al., 2007), RAE-1 induction 
in primary fibroblast cultures was not blocked by simultane-
ous addition of SB218078 and KU55933, which inhibit the 
B6 fibroblasts, although induction was greater for Raet1e 
transcripts than Raet1d transcripts (Fig. 1 C). In contrast, Mult1 
and H60b were induced only modestly, if at all (Fig. 1 C). In 
primary fibroblasts from the BALB/c and 129/J strains, which 
express RAE-1, , and , cell surface RAE-1 was strongly 
induced as detected with RAE-1–, –, and –specific anti-
body (unpublished data), suggesting that one or more of these 
RAE-1 isoforms is also induced in primary fibroblasts. Hence, 
several RAE-1 isoforms, but not MULT1 and H60b, were 
induced in proliferating fibroblasts.
RAE-1 induction in primary cultures was strongly 
blocked by inhibitors of cyclin-dependent kinases (CDKs; 
Roscovitine), the PI3K–mTOR pathway (LY294002, Rapa-
mycin), or the MAPK pathway (SB202190; Fig. 1 D and not 
depicted). Furthermore, after initiating cultures for 8 d with-
out inhibitors, the addition of Roscovitine or LY294002 
caused a significant inhibition of RAE-1 cell surface ex-
pression over the next 3 d (Fig. 1 E, top). Washing out the 
inhibitors and reculturing the cells for 3 d resulted in res-
toration of RAE-1 expression (Fig. 1 E, bottom). These in-
hibitors target distinct pathways but all of them severely 
inhibit proliferation.
We next addressed whether the constitutive RAE-1 ex-
pression by tumor cell lines was dependent on proliferative 
signals. Inhibiting CDKs with Roscovitine resulted in a 
marked reduction in RAE-1 expression by several RAE-1–
positive cancer cell lines, including TRAMP-C2 prostate ad-
enocarcinoma, MC38 colon carcinoma, and YAC-1 lymphoma 
cell lines (Fig. 1 F and not depicted). Inhibition of PI3K with 
LY294002 had similar effects (unpublished data).
To determine whether human NKG2D ligands are also 
regulated by proliferation, NKG2D ligand-positive HCT116 
human carcinoma cell lines were serum starved or treated 
with Roscovitine to inhibit proliferation. Serum starvation 
almost completely abrogated MICA/B expression and sig-
nificantly reduced ULBP2 expression, whereas Roscovitine 
inhibited both MICA/B and ULBP2 expression (Fig. 1 G). 
Therefore, the human MICA/B and ULBP2 NKG2D li-
gands, like mouse RAE-1 ligands, are subject to regulation 
by proliferative signals.
As further evidence for a role of proliferation in RAE-1 
expression, limiting the concentration of serum and therefore 
of serum growth factors caused a delay in RAE-1 induction 
in primary fibroblast cultures (Fig. 2 A). Furthermore, cells 
that had been cultured for >1 mo in 10% serum to maximally 
induce RAE-1 expression rapidly extinguished RAE-1 
cell surface and mRNA expression when deprived of serum 
(Fig. 2, B and C). Re-addition of 10% serum to the serum-
starved cells resulted in restoration of RAE-1 expression 
(Fig. 2 D). Serum starvation or cell cycle inhibitor treatment 
did not cause significant cell death, as very few of the cells 
were stained with Annexin V or 7-AAD after the treatments 
(Fig. 2 E). Furthermore, when proliferative conditions were 
reestablished by restoring serum or washing out inhibitors, 
most of the cells incorporated BrdU within 2–3 d, demonstrat-
ing that the treatments had not caused senescence (Fig. 2 F). 
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et al., 2005). Simultaneous deletion of the Atr gene using an 
inducible Cre system (Ruzankina et al., 2007) and inhibition 
of ATM (with KU55933) also did not prevent RAE-1 in-
duction (Fig. 3 A, right). ATM and ATR (ATM and Rad3 
related) are the two kinases that initiate most DNA damage 
responses and whose activity is necessary for maximal RAE-1 
expression in tumor cell lines (Gasser et al., 2005). These data 
key DNA damage response mediators checkpoint kinase 1 
(CHK1) and ataxia-telangiectasia mutated (ATM), respec-
tively (Fig. 3 A, left). We have previously shown that a com-
parable concentration of SB218078 inhibited the induction 
of RAE-1 on cell lines by each of the DNA damaging agents 
studied, and that ATM activation is critical for RAE-1 in-
duction by ionizing radiation and radiomimetic drugs (Gasser 
Figure 2. Proliferation is required for RAE-1 expression on primary fibroblasts. (A) Freshly prepared B6 adult mouse tail fibroblasts were cul-
tured in media supplemented with 2 or 10% serum for 3–7 d and harvested for flow cytometry analysis. (B and C) Fibroblasts that had been cultured 
for >1 mo were serum starved for 1–3 d and processed for staining (B) or RNA analysis (C). Means ± SD are shown. ***, P < 0.0005, unpaired Student’s  
t test. (D) Samples of serum-starved cells were supplemented with 10% serum and cultured for an additional 3 d. Data in A–D are representative of at least 
four experiments. (E) Proliferating (Untreated) fibroblasts, or fibroblasts subjected to serum starvation or treatment with LY294002, Roscovitine, or DMSO 
for 3 d, were stained with 7-AAD and Annexin-V to detect dead and apoptotic cells. (F) Fibroblasts that were serum starved for 3 d were fed with serum 
for 2 or 3 d in the presence of BrdU to label proliferating cells, before staining the cells intracellularly with BrdU antibodies. (G) Proliferating fibroblasts 
were serum starved for 3 d before adding 10% serum and BrdU (bottom) or BrdU only (top). After 24 h, cells were stained with BrdU and RAE-1 anti-
bodies. Gated BrdU+ and BrdU cells were examined for RAE-1 expression after excluding 7-AAD+ (dead) cells. (H) Proliferating fibroblasts were stained 
with RAE-1 antibody, permeabilized, and stained with propidium iodide. Cells in G1, S, or G2 phases of the cell cycle (left) were examined for RAE-1 
expression (right). (I) Freshly prepared tail cells were cultured on fibronectin-coated plates in DMEM supplemented with 10% serum, 100 ng/ml EGF, or no 
growth factor (EGF) for 3 d. Cell counts (right, cells/culture) and RAE-1 staining (left) are shown. Data in E–I are representative of two experiments.  
(J) Proliferating fibroblasts (Prol) or fibroblasts that were serum starved for 3 d (Starved) were used as target cells for IL-2–activated natural killer cells 
(LAKs) prepared from NKG2D-deficient (KO) mice or NKG2D WT littermate controls. NKG2D antibody was added to a reaction of WT LAKs with proliferat-
ing target cells to block the NKG2D receptor (WT/Prol/MI6). Means ± SD are shown. Data in J are representative of four experiments.
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Induction of RAE-1 on certain proliferating cells in vivo
To determine whether normal cellular proliferation in vivo 
can be associated with RAE-1 expression, we examined mouse 
fetal brain cells. At day 14 of gestation when cellular pro-
liferation is rampant (Daston et al., 2004), RAE-1 was 
readily detected on the surface of dissociated fetal brain cells 
and in fetal brain sections (Fig. 4, A and B), and the cells 
could be killed by WT but not Klrk1/ IL-2–activated NK 
cells (Fig. 4 C). By day 18 of gestation, when cell prolifera-
tion is considerably less pronounced (Daston et al., 2004), 
fetal brain cells failed to stain with RAE-1 antibody (Fig. 4 A). 
BrdU labeling for a limited time period confirmed that brain 
cells at day 14 labeled more rapidly than brain cells at day 18 
(Fig. 4 D). With longer labeling periods nearly all the day 14 
brain cells incorporated BrdU (not depicted), indicating that 
nearly all of them were proliferating at that stage and there-
fore providing an explanation for why the entire population 
rather than a subset was shifted higher in RAE-1 expression 
(Fig. 4 A). The finding that early but not late fetal brain cells 
express RAE-1, which is consistent with published Northern 
blot data (Zou et al., 1996), suggests that the expression of 
RAE-1 in embryonic brain cells is correlated with the rate 
of cell proliferation. NK cells are not present in significant 
numbers in early embryonic development, suggesting that 
RAE-1 expression on embryonic cells may not have any 
physiological consequence. Nevertheless, these findings with 
embryonic cells support the strong correlation between prolif-
eration and RAE-1 expression and extend the results to an 
in vivo system.
As another model for in vivo proliferation, wounded skin 
undergoing a healing reaction was analyzed for RAE-1 ex-
pression. 3 d after wounding, CD45-negative cells in the 
wound, especially in the epidermal layer, incorporated a large 
amount of BrdU over 24 h (Fig. 5 A). These data are consis-
tent with evidence that nonlymphoid cells, including kerati-
nocytes and fibroblasts, proliferate in wounds in response to 
serum growth factors (Singer and Clark, 1999). Interestingly, 
Raet1e mRNA was significantly induced in wounded skin 
established that the DNA damage response pathway depen-
dent on ATM, ATR, and/or CHK1 was not required for 
RAE-1 induction in these primary cultures.
The tumor suppressors p53, p19ARF, and p16INK4a are 
often induced in primary cultures (Kamijo et al., 1997). 
However, RAE-1 was induced normally in 5-d primary 
cultures of fibroblasts from mice with deletions of genes for 
p53, the p53 homologue p73, p19ARF, or both p19ARF and 
p16INK4a, arguing that RAE-1 induction is not dependent 
on these tumor suppressors (Fig. 3 B).
Figure 3. RAE-1 induction in primary fibroblast cultures is inde-
pendent of various stress pathways. (A) Fibroblasts were treated with 
DMSO, Roscovitine, or with a mixture of SB218078 (CHK1 inhibitor) and 
KU55933 (ATM inhibitor) for 3 d (left). Fibroblasts freshly prepared from 
Atrfloxed/ Cre-ERT2+ mouse tails were cultured in the absence (Atr+/) or 
presence (Atr/) of Tamoxifen (to induce Cre and delete loxP-flanked Atr 
alleles) for 5 d, and KU55933 or DMSO was added for the last 3 d (right). 
(B) Fibroblasts were freshly prepared from knockout mice that lacked the 
indicated genes (dashed lines) or WT controls (solid lines) and cultured for 
5 d. Dead (7-AAD+) cells were excluded. Each panel is representative of at 
least three independent experiments.
Figure 4. Induction of RAE-1 on cells in highly prolif-
erative tissues in vivo. (A) Single cell suspensions from E14 
and E18 fetal brains were stained with RAE-1. Dead (7AAD+) 
cells were excluded by gating. (B) 9-µm frozen sections of E14 
brain were stained with RAE-1 antibody (green) and DAPI 
(blue). Bars, 25 µm. (C) Killing of day 14 fetal brain cells by NK 
cells from Klrk1+/+ or Klrk1/ mice were measured using LIVE/
DEAD fixable dead cell stain kits, gating on CD45-negative cells. 
Effector/target ratio = 9:1. Means ± SD are shown. (D) BrdU 
incorporation of embryonic E14 or E18 brain cells after inject-
ing pregnant mothers with BrdU 16 h before sacrifice. Mean 
fluorescence intensity (MFI) of the entire population is shown 
on the right. Gated BrdU+ and BrdU cells stained similarly 
with RAE-1, consistent with the finding that nearly all the brain 
cells are proliferating at day 14 (see text). Data in this figure are 
representative of two to four independent experiments.
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compared with unwounded skin (Fig. 5 B) and abundant 
RAE-1 staining was observed in sections of wounded skin 
(Fig. 5 C). RAE-1 and BrdU staining were each detected mostly 
in the epidermal area, suggesting that they colocalize, but it 
was not possible to determine if RAE1 staining was restricted 
to BrdU+ cells for technical reasons. These findings provided 
another example where RAE-1 is induced in highly pro-
liferative tissue in vivo.
Previously published studies demonstrated that epidermal 
 T cells accelerate wound healing (Havran, 2000), that epi-
dermal  T cells express NKG2D (Girardi et al., 2001; 
Jamieson et al., 2002), and that activation of those  T cells 
in vitro by cultured keratinocytes depends on NKG2D inter-
actions (Whang et al., 2009). As shown in Fig. 5 D, wound 
healing was delayed in NKG2D-deficient (Klrk1/) mice, 
which contain normal numbers of epidermal  T cells 
(Jamieson et al., 2002). These data are consistent with a role 
of induced NKG2D ligands in wounded tissue in mediating 
a biological function of lymphocytes. It is notable that the 
impact of a deficiency in a single receptor (NKG2D) on the 
pace of wound healing was similar to that of a deficiency 
in all  T cells, arguing that NKG2D engagement plays an 
essential role in this function (Fig. 5 E).
Proliferative signals regulate RAE-1  
at the level of transcription
Induction of Raet1e transcripts could be the result of an in-
crease in the rate of Raet1e transcription or could reflect an 
increase in the stability of Raet1e transcripts that were pro-
duced by ongoing transcription. The rate of transcription, 
independent of posttranscriptional regulation, can be quanti-
fied with a nuclear run-on transcription assay, which deter-
mines the relative abundance of initiated transcripts in isolated 
nuclei that can be extended during a short incubation period 
in vitro (Gariglio et al., 1981; Core et al., 2008). We used a 
protocol in which isolated nuclei were incubated in the pres-
ence of Br-UTP plus other ribonucleotides for 15 min before 
isolation of the nuclear RNA, immunoprecipitation of the 
newly labeled RNA with Br-UTP–specific antibodies, and 
qRT-PCR quantification of the amount of Raet1e or control 
run-on transcripts in the immunoprecipitated samples (Core 
et al., 2008). Raet1e run-on transcripts were substantially 
more abundant in nuclei from fibroblasts proliferating in 10% 
serum than in nuclei from fibroblasts that had been serum 
starved for 3 d (Fig. 6 A). The low signal observed with 
Figure 5. Expression of RAE-1 in healing skin wounds. (A) BrdU 
was injected i.p. 2 d after imparting skin wounds, and the mice were sac-
rificed 1 d later. BrdU+ cells (red) and CD45+ cells (green) in sections of 
healing skin wounds. Examples of clear BrdU staining are indicated with 
arrows. D, dermis; E, epidermis. DAPI staining (blue) was not well defined 
as a result of permeabilization conditions. Two different sections are 
shown. (B) Skin segments from unwounded mice (d0), or skin surrounding 
and including wounds that had been imparted 1–3 d earlier were excised. 
Raet1e mRNA was quantified by qRT-PCR and normalized to 18s rRNA 
qRT-PCR results (n = 3). Means ± SD are shown. (C) Sections from 
wounded (3 d earlier) or unwounded skin were stained with RAE-1 anti-
body or isotype control antibody (green) with DAPI (blue). In some experi-
ments, the specificity of staining was confirmed by adding soluble 
recombinant RAE-1-Ig before RAE-1 antibody to block the staining.  
D, dermis; E, epidermis. RAE-1 staining of the epidermal layer was consis-
tently observed even in unwounded skin, but staining deeper in the tissue 
was restricted to wounded skin. Data in A–C are representative at least 
four experiments. Bars, 25 µm. (D) Three replicate experiments showing 
delayed wound healing in NKG2D-deficient (Klrk1/) mice compared 
with NKG2D WT (Klrk1+/+) littermates. After application of full thickness 
wounds, the area of the wound opening was determined on subsequent days. 
n = 5–11 wounds depending on the experiment. Means ± SD are shown. 
The asterisks denote significance (*, P < 0.05; **, P < 0.005; ***, P < 0.0005). 
(E) Analysis of wound closure in WT, TCR-–deficient (Tcrd/), or 
NKG2D-deficient mice. After application of full thickness wounds, the 
area of the wound opening was determined on the subsequent days. 
Means ± SD are shown. P < 0.05 for WT versus Tcrd/ at days 1 and 2;  
P < 0.05 for WT versus Klrk1/ at days 1 and 5. n = 11–25 wounds de-
pending on the combinations. The comparison of WT versus Klrk1/ was 
performed four times but the comparison including Tcrd/ was done 
only once.
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orientation. These data indicated that the Raet1 promoter is a 
locus of regulation dependent on the proliferative status of 
the cells.
Transcriptional regulation of Raet1e  
by the E2F family of transcription factors
Given that proliferative signals regulate the Raet1 promoter, 
we evaluated the role of transcription factors known to play 
a role in regulating the cell cycle. E2F family members are 
known to regulate transcription of genes encoding CDKs and 
many other genes involved in proliferation, and are negatively 
regulated by pRb (Chen et al., 2009). Three activating E2F 
family members (E2F1-3) are essential for proliferation of 
fibroblasts in culture, although they are partially redundant 
with each other (Wu et al., 2001). Consistent with a role in 
Raet1 regulation, the transcripts of all three activating E2Fs 
decreased with kinetics similar to the reduction in Raet1e 
transcripts in serum-starved fibroblasts (Leone et al., 2000; not 
depicted). Sequence analysis suggested that numerous putative 
E2F sites localized to the 5UTR, first exon, and first intron 
of the Raet1e gene, including two within the previously stud-
ied promoter fragment (Fig. 7, A and B). Considering that 
most active E2F1 binding sites (82%) overlap with CpG 
islands (Bieda et al., 2006), it was notable that the two putative 
starved nuclei incubated with Br-UTP was similar to the 
background signal nonspecifically precipitated in samples 
from proliferating nuclei incubated with UTP instead of 
Br-UTP (Fig. 6 A, UTP ctrl). These data showed that the 
increase in Raet1e expression in proliferating cells reflects in-
creased Raet1e transcription.
To determine whether proliferative signals regulate the 
Raet1e promoter, we initially defined the promoter using a 
combination of 5 RACE PCR, in silico promoter predic-
tion analysis, and transactivation assays (Fig. 6 B and not de-
picted). When inserted in the GL3-Basic luciferase reporter 
plasmid lacking a promoter or an enhancer, a fragment of 
274 bp that included 205 bp of the 5 flanking region and 
69 bp of the first exon, was active in supporting transcription 
when transfected transiently in cell lines that express Raet1 
but less so in a cell line that does not (Fig. 6 C). The frag-
ment was active only in the forward orientation, a character-
istic of most promoters.
When transiently transfected into cultured tail fibro-
blasts, the Raet1 promoter reporter plasmid was active in cells 
cultured in 10% serum but only when the Raet1 promoter 
was in the forward orientation (Fig. 6 D). In serum-starved fi-
broblasts, in contrast, promoter activity was at least threefold 
less active, and the activity was independent of promoter 
Figure 6. Transcriptional regulation of 
Raet1e by proliferation. (A) Nuclear run-on 
assays were performed in the presence of  
Br-UTP in proliferating fibroblasts (Serum) or 
3 d serum-starved fibroblasts. Labeled nuclear 
RNA was immunoprecipitated with Br-U anti-
body, reverse transcribed, and subjected to 
qPCR. As a control, the analysis was per-
formed with proliferating fibroblasts that 
were provided UTP instead of Br-UTP (UTP 
ctrl). No RT: reverse transcriptase was ex-
cluded from the RT reaction using RNA from 
proliferating fibroblasts. Means ± SD are 
shown. ***, P < 0.0005, unpaired Student’s  
t test. (B) Unbiased cap-dependent 5 RACE 
PCR was performed to define the 5 terminal 
end of the Raet1e transcripts. RNA samples 
from a panel of Raet1e+ cells were subject to 
5 RACE. In the first PCR reaction, a primer for 
the 5 adapter was combined with p4 as the 
3 primer. The product was subjected to 
nested PCR with the same 5 primer and 
primers p1, p2, or p3 as 3 primers. Numerous 
splice variants were deduced from the se-
quences of the various products. Exon 3 is 
variably included in different mRNAs. Exon 2 
was included, albeit rarely, in transcripts from 
one cell line, Nobo1 (not depicted). Exon 5, described in a previous study (Girardi et al., 2001), was not included in any of the Raet1e sequences we de-
tected. (C) Activity of the Raet1e promoter in cell lines. The pGL3 vector containing the Raet1e promoter fragment in forward (F) or reverse (R) orienta-
tions was transfected into RAE-1–expressing Tramp-C1 and Nobo1 cells or RAE-1–negative WEHI 7.1 cells and the cells were incubated in 10% serum for 
24 h. The activity of the SV40 promoter in the same reporter plasmid is shown for comparison (S). Means ± SD are shown. (D) Fibroblasts were trans-
fected with pGL3 basic vectors containing the Raet1e promoter (204 to +70) in forward or reverse orientation. The cells were incubated without serum 
() or with 10% serum (+) for 24 h (n = 3). Means ± SD are shown. ***, P < 0.0005, unpaired Student’s t test. Each panel in this figure is representative of 
at least three experiments.
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the Raet1e promoter construct, to levels even higher than 
observed when cells were grown in 10% serum (Fig. 8 A, 
left). E2F1 was much less effective in activating a Raet1e re-
porter plasmid in which both putative E2F sites were mu-
tated, indicating that E2F transcription factors directly bind 
and activate the Raet1e promoter construct (Fig. 8 A, right).
The promoter fragment also contains a putative c-MYC 
site (Unni et al., 2008), a finding which led to the proposal 
that c-MYC regulates the Raet1e gene. Compared with co-
transfection with an E2F expression vector, cotransfection 
of a c-MYC expression vector with the Raet1 promoter 
reporter caused a modest induction of luciferase (Fig. 8 B). 
Although this transactivation was significant, a reporter with an 
inactivating CACGTG to CAGCTG mutation (Kato et al., 
1992) in the previously reported c-MYC site was transacti-
vated equally as well as the WT reporter (Fig. 8 B). More-
over, although the WT Raet1e promoter supported luciferase 
production in proliferating cells (10% FCS) that had not been 
transfected with E2F or c-MYC, mutation of the putative 
MYC binding site in the promoter did not impair promoter 
activity in such cells (Fig. 8 C). In contrast, mutation of both 
E2F sites caused a significant reduction in promoter activity 
in proliferating cells. Collectively, these data indicated that 
E2F sites in the promoter were present in the Raet1e CpG is-
land (Fig. 7 B). In a competition electrophoretic mobility shift 
assay (EMSA), the Raet1e promoter fragment containing the 
two putative E2F sites competed with a labeled fragment con-
taining known E2F sites for binding to E2Fs in fibroblast nu-
clear extracts (Fig. 7 C). A Raet1e promoter fragment in which 
the core sequences of both putative E2F sites (SSCG) were 
mutated to ATAT competed substantially less efficiently, dem-
onstrating the role of these sites in E2F binding.
Chromatin immunoprecipitation assays confirmed that 
E2F1, E2F2, and E2F3 were associated with the Raet1 pro-
moter in chromatin extracted from proliferating cells (Fig. 7 D, 
left). Approximately fourfold less E2F was associated with 
the Raet1 promoter in chromatin extracted from fibroblasts 
that had been starved of serum for 3 d (Fig. 7 D, left). E2Fs 
associated similarly with the p107 gene, a known target for all 
three activating E2Fs (Iaquinta et al., 2005; Fig. 7 D, right).
To investigate whether E2F1 activates the Raet1e pro-
moter reporter construct described in Fig. 6 D, fibroblasts 
maintained in 0% serum were cotransfected with the reporter 
construct and increasing amounts of a pcDNA vector encod-
ing E2F1. Compared with cotransfection with empty vector, 
cotransfection with E2F1 caused a strong transactivation of 
Figure 7.  E2F transcription factors bind to the Raet1e promoter. (A) Putative E2F binding sites with consensus sequence TTTSSCGC (S = C or G, 
with up to two mismatches allowed only in the three T residues (Schulze et al., 1995; Bieda et al., 2006; Rabinovich et al., 2008) were localized throughout 
the Raet1e gene. (B) A schematic of the 5end of the Raet1e locus. The region from 60 to +1 is enlarged to show the putative E2F binding sites. The 
CpG island is shown as a hatched box. (C) Competition EMSA showing binding of a Raet1e promoter fragment to E2F in fibroblast nuclear extracts.  
A labeled probe containing E2F sites from the DHFR promoter was incubated with fibroblast nuclear extract (NE) before gel analysis. Binding was com-
peted away by preincubating the extract with a 100-, 200-, or 400-fold excess of unlabeled oligonucleotides, including the same DHFR promoter oligo-
nucleotide, a Raet1e promoter oligonucleotide, or mutated versions of these oligonucleotides in which the E2F binding sites were replaced with 
nonfunctional sites (Mut DHFR and Mut Raet1e). (D) ChIP assays showing association of E2F1, E2F2, and E2F3 with the Raet1e promoter in proliferating 
(Serum) or starved fibroblasts. Control IP with IgG isotype is shown. PCR was performed with PCR primers designed to yield a 165 bp product correspond-
ing to 147 to +18 of the Raet1e promoter (left) or primers of the p107 promoter region were used (right). The input lane represented 0.3% of the 
amount of chromatin used in the ChIP assays. The gel was cut at every set of four semiquantitative PCR and aligned. Black lines indicate that intervening 
lanes were spliced out. Each panel in this figure is representative of four independent experiments.
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E2F2 promoter region abrogated transactivation of the E2F2 
promoter (Leung et al., 2008). Collectively, the data demon-
strate that E2F transcription factors bind and transactivate the 
Raet1e promoter, play an important role in supporting Raet1 
transcription in proliferating cells, and function potentially 
redundantly in driving Raet1 transcription.
DISCUSSION
Deregulated proliferation is a hallmark of malignancy, and it is 
known that infections can deregulate proliferative pathways as 
well (Lavia et al., 2003). Although a previous study implied 
that expression of MICA is correlated with proliferation, it was 
not ruled out that the DNA damage response or other stress 
pathways induced in proliferating cells accounted for the 
MICA expression (Venkataraman et al., 2007). In contrast, in 
our analysis of RAE-1 induction, we ruled out numerous stress 
pathways and tumor suppressors known to be activated in pro-
liferating cells, and we demonstrated a direct linkage with E2F 
transcription factors, which regulate the cell cycle. The dem-
onstration that proliferation-related signals profoundly induce 
Raet1e transcription via the action of E2F transcription factors 
provides a new conceptual framework for understanding the 
role of the NKG2D–ligand axis in immune responses.
It is notable that RAE-1 induction in proliferating primary 
fibroblasts was not dependent on the DNA damage checkpoint 
E2Fs act directly on the Raet1e promoter in proliferating 
cells, whereas c-MYC is likely to act indirectly, probably by 
inducing E2F transcription, an activity of c-MYC which was 
previously documented elsewhere (Leone et al., 1997).
Transduction of E2F1, E2F2, or E2F3 in cells cultured 
without serum also transactivated the endogenous Raet1e gene 
(Fig. 8 D), demonstrating that E2Fs induce transcription of the 
chromatinized Raet1e gene in its natural context. The extent 
of induction with different E2Fs varied in different experiments 
but, in each case, was roughly commensurate with induction of 
a known E2F target, DHFR, determined in parallel (Fig. 8 D).
Finally, to investigate whether endogenous E2Fs play a 
necessary role in supporting Raet1e gene expression, E2F ex-
pression in proliferating fibroblasts was inhibited by transfec-
tion of siRNAs specific for each activating E2F. SiRNAs 
against E2F1, E2F2, and E2F3 each caused a substantial re-
duction in Raet1e transcripts to nearly the same extent as a 
mixture of the three siRNAs (Fig. 8 E). Of note, although 
each E2F siRNA targeted nonhomologous sequences in the 
corresponding target E2F mRNA, they each caused reductions 
in the amounts of the other two activating E2Fs (unpublished 
data). This is likely a result of the fact that E2F transcription 
factors autoregulate E2F genes, which had been documented 
previously based on the findings that each E2F promoter 
contains E2F binding sites, and mutation of E2F sites in the 
Figure 8. Transactivation of Raet1e expression by E2Fs, and siRNA knockdowns. (A and B) Fibroblasts were transfected with 50 ng pGL3 vector 
containing the Raet1e promoter segment or corresponding segments in which putative E2F sites (A) or a putative MYC site (B) were mutated, along with 
varying amounts of pcDNA encoding E2F1 or MYC (0, 100, 250, or 750 ng in the left panel of A, and 0, 250, or 750 ng in the remaining panels). Cells were 
incubated in 0% serum for 24 h except the 10% serum sample in the left panel of A. Open and shaded boxes represent E2F and MYC sites, respectively; Xs 
indicate mutations that prevent factor binding. (C) Primary fibroblasts were transfected with the reporter plasmid containing the WT Raet1e promoter or 
the promoter in which both E2F sites were mutated, and the MYC site was mutated or all three sites were mutated. The transfected cells were incubated 
for 40 h in 0 or 10% serum before analysis of reporter activity. (D) Endogenous Raet1e expression in fibroblasts transduced with E2F1, E2F2, E2F3, or GFP 
only (empty) and cultured for 48 h in the absence of serum. DHFR is a known E2F target gene. n = 3. (E) siRNA knockdowns of E2Fs separately or together 
inhibit Raet1e expression in proliferating fibroblasts 48 h later (P < 0.0005 for all E2F groups vs. negative control). Data were normalized to 18S rRNA 
amounts and then to the all star negative control sample. n = 89. Each result in this figure is representative of at least four independent experiments. 
The asterisks denote significance (*, P < 0.05; **, P < 0.005).
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by our finding that proliferating brain cells at day 18 of gesta-
tion, which proliferate less than those at day 14, do not ex-
press appreciable RAE-1 (Fig. 4 A). Also consistent with 
this idea is that substantially more E2F1 plasmid was required 
for induction of Raet1 in our experiments than was required 
for induction of other targets as reported elsewhere (Ohtani 
et al., 1995; Stiewe and Pützer, 2000; Ma et al., 2003).
In addition, cell types are likely to vary in the extent to 
which proliferation suffices to induce NKG2D ligands, as 
suggested by the fact that proliferating T cells in vitro ex-
pressed relatively small amounts of NKG2D ligands or none 
at all (Diefenbach et al., 2000; Cerboni et al., 2007). It is pos-
sible that ligand expression is repressed specifically in lym-
phocytes, which proliferate as part of their normal program 
and are surrounded by NK cells. Alternatively, another sig-
nal, in addition to the proliferative signal, may be required for 
ligand expression in those cells.
Indeed, many studies have identified other stress pathways 
that regulate NKG2D ligands, which may act cooperatively 
with proliferative signals to regulate RAE-1 and other NKG2D 
ligands. Many of these pathways act at different stages of bio-
genesis of NKG2D ligands. For example, the DNA damage 
response pathway induces Raet1 expression, but it acts to aug-
ment the stability of Raet1 transcripts and does not augment 
transcription (unpublished data). Heat shock induces the 
MULT1 protein by decreasing the rate of ubiquitin-dependent 
MULT1 degradation (Nice et al., 2009). The PI3K pathway, 
which supports RAE-1 expression in both virus-infected cells 
and tumor cell lines, may act in part by regulating protein 
translation as well as by stimulating cell proliferation (Tokuyama 
et al., 2011). Some stress pathways augment transcription 
as well, including the heat shock pathway, which regulates 
MICA transcription (Venkataraman et al., 2007), and the 
tumor suppressor p53, which augments transcription of one 
of the human ULBP proteins (Textor et al., 2011).
We propose that in some cells or circumstances, these 
levels of regulation may serve as serial checkpoints, regulated 
by distinct stimuli, to ensure that ligands are induced only in 
diseased cells and not in normal cells. In certain cases, for ex-
ample in fibroblasts stimulated to undergo intense prolifera-
tion, the posttranscriptional checkpoints may be overwhelmed 
as a result of the magnitude of Raet1e transcriptional induc-
tion. Understanding the cooperation of the individual sig-
nals and stress pathways and their contribution for different 
ligands and in different tissues or tumors will provide addi-
tional insights concerning the biological function of NKG2D 
and, by extension, NK recognition.
Redundancy and activities of E2F transcription factors
Notably, in addition to regulating cell cycle progression, E2F 
can exert a role in the DNA damage response by inducing 
target genes that function in DNA repair and recombination 
and DNA damage checkpoints. E2F1 is directly phosphory-
lated by ATM, and acetylation, also driven by the DNA damage 
response, potentiates the apoptotic functions of E2F1. Therefore, 
E2Fs may play a role in both NKG2D ligand transcription 
response pathway, which is initiated by ATM or ATR. A role 
of the DNA damage response in ligand induction has been 
demonstrated in numerous cell lines treated with genotoxic 
drugs and in untreated tumor cells that constitutively express 
NKG2D ligands (Gasser et al., 2005; Cerboni et al., 2007). 
In the present case, as well as in an instance of virus-induced 
RAE-1 expression in fibroblast cell lines (Tokuyama et al., 2011), 
the DNA damage response does not play a significant role. The 
basis of these differences is not known, but it could simply re-
flect redundancy in the mechanisms of NKG2D ligand induc-
tion. For example, the DNA damage response acts primarily to 
stabilize Raet1 mRNA, whereas E2F acts transcriptionally, so it 
is possible that sufficiently strong transcriptional activation of 
RAE-1 in proliferating cells provides robust cell surface RAE-1 
despite the absence of mRNA-stabilssizing conditions. Alterna-
tively, the cellular requirements for ligand induction may differ 
depending on the differentiation or activation state of the cells.
Proliferation in normal tissues and RAE-1 expression
Obviously, proliferation is not restricted to malignant cells but 
also occurs during development of normal tissues and during 
processes of tissue renewal. Our data showed that RAE-1 in-
duction occurs even in normal cells undergoing proliferation 
in vivo, that is, in embryonic day 14 (E14) embryonic brain 
cells or in cells in healing wounds. Notably, E2F transcription 
factors are also strongly induced in healing wounds (D’Souza 
et al., 2002; unpublished data) and are expressed strongly in 
midgestation embryonic brain tissue, with the levels diminish-
ing later in gestation (Dagnino et al., 1997). RAE-1 induction 
in normal tissues was surprising because it seems potentially 
maladaptive for normal proliferating cells to display NKG2D 
ligands. Fetal brain cells are presumably under no threat, how-
ever, because mature NK cells appear after birth, after RAE-1 
expression on brain cells is extinguished. In the case of cells 
in healing wounds, in contrast, our data suggest that expression 
of RAE-1 and another skin-specific NKG2D ligand (H60c; 
Whang et al., 2009) by cells in the wound has a beneficial ef-
fect by accelerating wound healing. The specialized  T cells 
that reside in the skin (Havran, 2000; Girardi et al., 2001; Gray 
et al., 2011) express NKG2D (Jameson et al., 2002) and 
respond to stimulation by producing growth factors that 
accelerate wound healing (Havran, 2000). In addition to up-
regulating RAE-1, wounded skin cells up-regulate another 
NKG2D ligand H60c, at least at the mRNA level (Whang 
et al., 2009), and we suspect that both ligands play a role in the 
acceleration of wound healing documented here. It remains 
possible that distinct stress pathways that are activated in wounded 
skin (Oberringer et al., 1995; Schäfer and Werner, 2008) coop-
erate with proliferative signals to amplify RAE-1 expression.
Integration of stress and proliferation  
in the induction of RAE-1e
Whereas proliferation is important for inducing Raet1e tran-
scription, it is probably not sufficient for inducing RAE-1 at 
the cell surface in all conditions or cell types. One important 
factor is likely to be the intensity of proliferation, as suggested 
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centrifugation. Cells were resuspended in lysis buffer (swelling buffer + 0.5% 
NP-40 + 2 U/ml Superase In [Ambion] + 10% glycerol) and pipetted 20–
30 times with a p1000 pipette to disrupt the membrane. After washing with 
lysis buffer, pelleted cells were resuspended with 100 µl of freezing media 
(50 mM Tris-HCl, pH 8.3, 40% [vol/vol] glycerol, 5 mM MgCl2, 0.1 mM 
EDTA + 10× protease inhibitor [complete mini, EDTA-free; Roche]) and fro-
zen. For the assays, 100 µl nuclei solution was mixed with 0.1 ml reaction buffer 
(10 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 300 mM KCl, 0.5 mM ATP/
CTP/GTP, and Br-UTP [Invitrogen]) and incubated at 30°C for 15 min. 
DNaseI was added to the mixture and the reaction was incubated for another 
30 min at 37°C, followed by TRIZOL addition and RNA extraction.
Immunoprecipitation of Br-UTP–labeled RNA was performed as 
previously described (Core et al., 2008) with modifications. BrdU antibody–
agarose complex (IIB5-AC; Santa Cruz Biotechnology, Inc.), which cross-
reacts with Br-UTP, was blocked with 0.1% Polyvinylpyrrolidone and 
1 µg/ml BSA. The labeled RNA was incubated with antibody–bead com-
plexes in binding buffer (0.5× SSPE, 1 mM EDTA, and 0.05% Tween) for 
60 min. After washing (5× with binding buffer; 1× with low salt buffer 
[0.2× SSPE, 1 mM EDTA, and 0.05% Tween), 1× with high salt buffer 
[low salt buffer + 137.5 mM NaCl], and 2× with TET buffer [TE + 0.05% 
Tween]), the RNA–antibody complex was eluted 4× with 125 µl of elution 
buffer (20 mM DTT, 300 mM NaCl, 5 mM Tris-HCl, pH 7.5, 1 mM 
EDTA, and 0.1% SDS) at 37°C for 5 min with vortexing every minute. The 
combined eluates were extracted with TRIZOL (Invitrogen).
Quantitative RT-PCR. Total RNA isolated using TRIzol (Invitrogen) 
was digested with DNase (Ambion) and reverse transcribed with Superscript 
III reverse transcription (Invitrogen). Triplicate amplification mixtures were 
prepared with 0.01–1 µg cDNA, SYBR GreenER SuperMix (Invitrogen), 
and 200 nM of forward and reverse primers and cycled using the ABI 7300 
Real-Time PCR system as follows: 50°C for 2 min, 95°C for 10 min, and 
40 cycles of 95°C for 15 s and 60°C for 60 s. All results were normalized 
based on parallel qRT-PCR of 18s rRNA.
Primers. See Table 1 for a list of primers.
Plasmids, transfection, and transduction. The pGL3-Raet1e promoter 
constructs consisted of promoter fragments inserted between the HindIII 
and XhoI sites in the pGL3 vector. The E2F1 (56 and 10) and C-MYC 
binding site mutants were made with the QuikChange kit (Agilent Technol-
ogies). pcDNA-CMV-E2F1 (a gift from P.J. Farnham, University of Califor-
nia, Davis, Davis, CA) was described previously (Li et al., 1994). pCMV6-E2F2 
was purchased from OriGene. pCX-c-Myc plasmid was purchased from 
Addgene. pBABE-E2F1, E2F3, and pMSCV-E2F2 retroviral expression vec-
tors were gifts from S. Gasser (National University of Singapore, Singapore).
All plasmid and siRNA transfections were performed with Lipofectamine 
2000 (Invitrogen). Plasmid transfections were done in Opti-MEM (Invitrogen) 
using 0.8 µg of total DNA and 2 µl lipofectamine per well in 24-well plates. 
and the posttranscriptional regulation exerted by the DNA 
damage response.
E2F1, 2, and 3 redundantly regulate many transcriptional 
targets and the proliferation of mouse embryonic fibroblasts 
in vitro (Wu et al., 2001). Our transactivation data suggest 
they redundantly regulate Raet1e, as well, but we could not 
corroborate this in knockdown experiments because knock-
downs of each E2F family member dampened expression 
of the others. Notably, however, we observed no defect in 
RAE-1 expression in proliferating fibroblasts from E2F1/ 
mice, consistent with the proposal that E2F1–3 redundantly 
regulate Raet1 (unpublished data).
The findings reported here link cell cycle control directly to 
the induction of NKG2D ligands and provide a new framework 
for understanding the regulation of this component of the im-
mune system. Further analysis of the roles played by E2Fs in 
regulating NKG2D ligands may provide new approaches for 
understanding how processes associated with tumorigenesis and 
infections lead to elimination of unhealthy cells by immune cells. 
At the same time, the results provide new perspectives for un-
derstanding the roles of NKG2D in processes beyond tumori-
genesis and infections, such as wound healing.
MATERIALS AND METHODS
Mice, cells, antibodies, and reagents. Fibroblasts from >8 wk old 
C57BL/6J or specific knockout mice were prepared as previously de-
scribed (Lander et al., 1978) in DMEM with 10% FCS, 100 U/ml penicillin, 
100 µg/ml streptomycin, 0.2 mg/ml glutamine, 10 µg/ml gentamycin sulfate, 
20 mM Hepes, and 50 µM 2-mercaptoethanol. For Atr deletion in ear fibro-
blasts from Atrfloxed/Cre-ERT2+ mice (Ruzankina et al., 2007), fibroblasts 
were cultured in the presence of 100 nM tamoxifen, which was changed 
every day. Pan–RAE-1 mAb (186107), RAE-1 mAb (205001), and MULT1 
mAb (237104) were purchased from R&D Systems. PE-conjugated goat 
F(ab’)2 fragment to rat IgG was purchased from Jackson ImmunoResearch 
Laboratories. BrdU staining was performed with biotin-conjugated BrdU 
antibody (MoBU-1; BioLegend) using the BrdU flow kit (BD). SB218078 
was purchased from Calbiochem and KU55933 was purchased from VWR. 
All animal procedures were performed according National Institutes of 
Health guidelines under protocols approved by the University of California 
Animal Care and Use Committee.
Nuclear run-on transcription assay. Nuclei were isolated by incubating 
fibroblast cell pellets with 5 ml of swelling buffer (10 mM Tris-HCl, pH 7.5, 
2 mM MgCl2, and 3 mM CaCl2) and incubated at 4°C for 5 min, followed by 
Table 1. Primers
Gene Forward Reverse
Raet1e 5-CAGGTGACCCAGGGAAGATG-3 5-CTCAACTCCTGGCACAAATCG-3
Unspliced Raet1e 5-ATTTGTGCCAGGAGTTGAGG-3 5-CCTGCATGTACTCTGCCCTT-3
E2f1 5-GCCCTTGACTATCACTTTGGTCTC-3 5-CCTTCCCATTTTGGTCTGCTC-3
E2f2 5-GCCACCACCTACTACACTTCG-3 5-CGGAATTCAGGGACCGTAG-3
E2f3 5-GCCTCTACACCACGCCACAAG-3 5-TCGCCCAGTTCCAGCCTTC-3
c-Myc 5-CAGAGGAGGAACGAGCTGAAGCGC-3 5-TTATGCACCAGAGTTTCGAAGCTGTTCG-3
DHFR 5-CTGGTTCTCCATTCCTGAGAAG-3 5-GCCACCAACTATCCAGACCATG-3
18s rRNA 5-GTCTGTGATGCCCTTAGATG-3 5-AGCTTATGACCCGCACTTAC-3
Raet1e promoter 5-GGCTGTAATTTGCACACTCG-3 5-GGAGCAGGTAACTGACTACAGC-3
p107 promoter 5-TTAGAGTCCGAGGTCCATCTTCT-3 5-GGGCTCGTCCTCGAACATATCC-3
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Chromatin immunoprecipitation. Fibroblasts were harvested with tryp-
sin and resuspended in DMEM 10% FCS. Fixing solution (0.1 M NaCl, 
1 mM EDTA, 0.5 mM EGTA, 50 mM Hepes, pH 8.0, and 11% formalde-
hyde) was added to the medium to achieve a final concentration of 1% 
formaldehyde and cross-linking proceeded for 10 m at RT. After adding 
glycine to a concentration of 0.125 M to stop the reaction and washing twice 
with cold PBS, lysates were sonicated to shear the genomic DNA into 200–
600 bp fragments (30% amplification, 20 s, 8–10×). The previous day, poly-
clonal antibodies specific for E2F1 (KH95; Santa Cruz Biotechnology, Inc.), 
E2F2 (C-20; Santa Cruz Biotechnology, Inc.), or E2F3 (C-20; Santa Cruz 
Biotechnology, Inc.) were blocked with BSA and incubated with Dynal 
beads (Invitrogen) overnight at 4°C. Sonicated samples were immuno-
precipitated overnight at 4°C with antibody–beads complexes. After exten-
sive washing (3× with low salt wash buffer, 1× with high salt wash buffer, 1× 
with LiCl Wash Buffer, and 2× with TE Buffer), the complexes were eluted 
at 65°C for 30 min with elution buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 
and 1% SDS). The cross-links were reversed by adding NaCl to a final con-
centration of 0.2 M and heating the samples to 65°C overnight. The eluted 
material was phenol-chloroform extracted, ethanol precipitated, and resus-
pended in 50 µl of water.
EMSA. 4 µg of fibroblast nuclear extract was incubated with the 20 fmol of 
a biotinylated DNA probe at room temperature for 20 min in 1× binding 
buffer (Thermo Fisher Scientific) + glycerol + MgCl2. Complexes were 
separated on a 6% polyacrylamide non-denaturing gel and transferred to a 
nylon membrane for detection using the light-shift EMSA kit (Thermo 
Fisher Scientific). In the competition experiments, varying amounts of unla-
beled competitor oligonucleotides were preincubated with extract for 20 min 
before adding biotinylated DNA.
The probe was a 5 biotin-labeled 26 bp oligonucleotide and its comple-
ment consisting of a segment of the DHFR promoter that contains E2F 
sites (Li et al., 1994; 5-GCTGCGATTTCGCGCCAAACTTGACG-
3, the two overlapping E2F sites are underlined). As unlabeled competi-
tors, we used the same DHFR promoter segment, a DHFR promoter oligo 
with mutated E2F sites (5-CGTCAAGTTTATATATAAATCGCAGC-3, 
mutant base pairs underlined; Li et al., 1994), a 61-bp oligonucleotide cor-
responding to a segment of the Raet1e promoter that contains E2F sites 
(5-GGCTTCCCCGCGGGCGGCGCCTTCCGCCCTCCGCCATTG-
TGTCCATCCCCTGCCCGCAGAG-3, E2F sites underlined), and a 
Raet1e promoter oligonucleotide in which the E2F sites were mutated (5-
GGCTTCATATCGGGCGGCGCCTTCCGCCCTCCGCCATTGTG-
TCCATCCCCTGATATCAGAG-3, mutant base pairs underlined).
Statistical analysis. Data were analyzed using an unpaired Student’s t test. 
Values of P < 0.05 were considered statistically significant.
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